var data = {
    "modulesList": [
        {
            "title": "<b>Chimeric Antigen Receptor Therapies (Car-Ts) And Their Potential Impact On Hematologic Cancer Care</i></b>",
            "href": "https://ce.asimcme.com/hematologyconsults/content/chimeric-antigen-receptor-therapies-car-ts-and-their-potential-impact-hematologic-cancer#group-tabs-node-course-default1",
            "description": "Chimeric antigen receptor T-cell (CAR-T) therapy has recently emerged as a new treatment strategy for patients with relapsed and refractory leukemia and lymphoma, a patient population that usually has few good treatment options and poor long-term survival.",
            "credits":'CME/CNE Credits: <span style="color:#153687;">0.5</span>',
            "faculty": 'Faculty: <span style="color:#153687;">David S. Ettinger, MD</span>',
            "expiration": 'Expires: <span style="color:#153687;">7/30/2020</span>',
            "position" :  "2",
            "active": "1"

        },
        {
            "title": "<b>Hematology Consults:<br><i>Addressing Treatment Options For Multiple Myeloma</i></b>",
            "href": "https://ce.asimcme.com/hematologyconsults/content/addressing-treatment-options-multiple-myeloma#group-tabs-node-course-default1",
            "description": "Multiple Myeloma (MM) is a malignant B-cell lymphoproliferative disorder that is the second most common hematologic malignancy, accounting for approximately 10% of hematologic cancers.",
            "credits":'CME/CNE Credits: <span style="color:#153687;">0.5</span>',
            "faculty": 'Faculty: <span style="color:#153687;">David S. Ettinger, MD</span>',
            "expiration": 'Expires: <span style="color:#153687;">10/10/2018</span>',
            "position" :  "1",
            "active": "1"

        }
    ]
};
var activeIndex = 0;
var btnType = "";
var modulesDB;
var currentModule;
var isNew = false;

